Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

During Operation Protective Edge, Hadassah's Hospitals Care for Terror Victims and Perpetrators

Within a 24-hour period, the Iron Dome shot down rockets in the area close to Hadassah's hospital in Ein Kerem, and new terror victims and one suspected terrorist were taken to HMO for treatment.

When a 10-month-old boy was injured after Palestinians threw rockets from a light rail train, Magen David Adom, the national emergency service, transported the boy to Hadassah Ein Kerem Hospital.

Read in The Jerusalem Post: Hospitals Must Treat Terrorists, Too

A 20-year-old Arab resident of Jerusalem's Shuafat neighborhood was wounded on Saturday in an exchange of fire with Israeli security forces as he was apprehended on suspicion he had earlier fired shots from Shuafat, a Palestinian neighborhood of East Jerusalem, toward the Pisgat Ze'ev neighborhood. He, too, was taken to Hadassah in Ein Kerem.

On Saturday night, young couple Yedaya and Hadassah Sharchaton were driving home to Yatir, south of Hebron, from visiting their families in Jerusalem with their year-old daughter Nitzan.

Terrorists threw heavy rocks, smashing the windshield, hitting Yedaya in the face and seriously injuring him. The car flipped over into a ditch on the side of the road. The family was brought to Hadassah in Ein Kerem, where baby Nitzan was kept for observation and Yedaya is currently being treated in the Intensive Care Unit.

This evening, sirens rang in the area around Hadassah in Ein Kerem as a rocket barrage came from Gaza; the Iron Dome system shot down the rockets.

Read in The Jerusalem Post: Terrorist Shot in East Jerusalem

Date: 8/25/2014


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America